
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs
Senthilnath Lakshmanachetty, Joselyn Cruz-Cruz, Eric Hoffmeyer, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 893-893
Open Access | Times Cited: 36
Senthilnath Lakshmanachetty, Joselyn Cruz-Cruz, Eric Hoffmeyer, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 893-893
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Conjugation of Macrophage-Mimetic Microalgae and Liposome for Antitumor Sonodynamic Immunotherapy via Hypoxia Alleviation and Autophagy Inhibition
Gao Cheng, Cheryl H. T. Kwong, Qingfu Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 4034-4049
Closed Access | Times Cited: 80
Gao Cheng, Cheryl H. T. Kwong, Qingfu Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 4034-4049
Closed Access | Times Cited: 80
Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma
Subhajit Ghosh, Jiayi Huang, Matthew Inkman, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 680
Open Access | Times Cited: 47
Subhajit Ghosh, Jiayi Huang, Matthew Inkman, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 680
Open Access | Times Cited: 47
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 39
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 39
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
The Role of Myeloid Cells in GBM Immunosuppression
Ya-Jui Lin, Caren Yu-Ju Wu, Janet Y. Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Ya-Jui Lin, Caren Yu-Ju Wu, Janet Y. Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
Exosomes as drug delivery systems in glioma immunotherapy
Xinqing Hao, Shiming Wang, Liang Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Xinqing Hao, Shiming Wang, Liang Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma
Verena Panitz, Saša Končarević, Ahmed Sadik, et al.
Theranostics (2021) Vol. 11, Iss. 19, pp. 9217-9233
Open Access | Times Cited: 40
Verena Panitz, Saša Končarević, Ahmed Sadik, et al.
Theranostics (2021) Vol. 11, Iss. 19, pp. 9217-9233
Open Access | Times Cited: 40
Tumor Microenvironment and Microvascular Density in Human Glioblastoma
Roberto Tamma, Giuseppe Ingravallo, Tiziana Annese, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 11-11
Open Access | Times Cited: 24
Roberto Tamma, Giuseppe Ingravallo, Tiziana Annese, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 11-11
Open Access | Times Cited: 24
GBM immunotherapy: Exploring molecular and clinical frontiers
Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, et al.
Life Sciences (2024) Vol. 356, pp. 123018-123018
Closed Access | Times Cited: 5
Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, et al.
Life Sciences (2024) Vol. 356, pp. 123018-123018
Closed Access | Times Cited: 5
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
Andrea Franson, Brandon L. McClellan, María L. Varela, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Andrea Franson, Brandon L. McClellan, María L. Varela, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
Payal Aggarwal, Wen Luo, Katherine C. Pehlivan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Payal Aggarwal, Wen Luo, Katherine C. Pehlivan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion
Yu Chen, Yanquan Xu, Huakan Zhao, et al.
Cancer Letters (2023) Vol. 564, pp. 216208-216208
Closed Access | Times Cited: 12
Yu Chen, Yanquan Xu, Huakan Zhao, et al.
Cancer Letters (2023) Vol. 564, pp. 216208-216208
Closed Access | Times Cited: 12
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
Anita Kalluri, Pavan P. Shah, Michael Lim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2020-2020
Open Access | Times Cited: 11
Anita Kalluri, Pavan P. Shah, Michael Lim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2020-2020
Open Access | Times Cited: 11
Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives
S. Rajkumari, Jaspreet Singh, Usha Agrawal, et al.
International Immunopharmacology (2024) Vol. 142, pp. 112949-112949
Closed Access | Times Cited: 4
S. Rajkumari, Jaspreet Singh, Usha Agrawal, et al.
International Immunopharmacology (2024) Vol. 142, pp. 112949-112949
Closed Access | Times Cited: 4
A novel method for isolation of tumor infiltrating myeloid-derived suppressor cells from human lung tumor tissue
Marta Piqueras-Nebot, Marta Benet, Miriam Estors, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Marta Piqueras-Nebot, Marta Benet, Miriam Estors, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Surface-engineered chlorella alleviated hypoxic tumor microenvironment for enhanced chemotherapy and immunotherapy of first-line drugs
Gao Cheng, Cheryl H. T. Kwong, Qingfu Wang, et al.
Materials Today (2022) Vol. 58, pp. 57-70
Closed Access | Times Cited: 18
Gao Cheng, Cheryl H. T. Kwong, Qingfu Wang, et al.
Materials Today (2022) Vol. 58, pp. 57-70
Closed Access | Times Cited: 18
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16
VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells
Yanlong Tian, Gao Xiao, Xuechao Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Yanlong Tian, Gao Xiao, Xuechao Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Emerging Biomarkers for Immunotherapy in Glioblastoma
Nadia Mensali, Else Marit Inderberg
Cancers (2022) Vol. 14, Iss. 8, pp. 1940-1940
Open Access | Times Cited: 9
Nadia Mensali, Else Marit Inderberg
Cancers (2022) Vol. 14, Iss. 8, pp. 1940-1940
Open Access | Times Cited: 9
Mapping the tumor-infiltrating immune cells during glioblastoma progression
Senthilnath Lakshmanachetty, Siddhartha S. Mitra
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 826-828
Closed Access | Times Cited: 9
Senthilnath Lakshmanachetty, Siddhartha S. Mitra
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 826-828
Closed Access | Times Cited: 9
Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy
Muhammad Ali, Giulia Fulci, Mantas Grigalavicius, et al.
Neoplasia (2022) Vol. 26, pp. 100779-100779
Open Access | Times Cited: 8
Muhammad Ali, Giulia Fulci, Mantas Grigalavicius, et al.
Neoplasia (2022) Vol. 26, pp. 100779-100779
Open Access | Times Cited: 8
Detailed review on phytosomal formulation attenuating new pharmacological therapies
Jyotsana Dwivedi, Pranjal Sachan, Pranay Wal, et al.
Advances in Traditional Medicine (2023) Vol. 24, Iss. 3, pp. 659-684
Closed Access | Times Cited: 4
Jyotsana Dwivedi, Pranjal Sachan, Pranay Wal, et al.
Advances in Traditional Medicine (2023) Vol. 24, Iss. 3, pp. 659-684
Closed Access | Times Cited: 4
Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants
Fei Gao, Xiaoqing You, Liu Yang, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 5, pp. 280-308
Closed Access | Times Cited: 1
Fei Gao, Xiaoqing You, Liu Yang, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 5, pp. 280-308
Closed Access | Times Cited: 1